Sign In
Buy PRLB
Proto Labs Earnings Calls
| Release date | Oct 31, 2025 |
| EPS estimate | $0.390 |
| EPS actual | $0.470 |
| EPS Surprise | 20.51% |
| Revenue estimate | 129.071M |
| Revenue actual | 135.366M |
| Revenue Surprise | 4.88% |
| Release date | Jul 31, 2025 |
| EPS estimate | $0.330 |
| EPS actual | $0.410 |
| EPS Surprise | 24.24% |
| Revenue estimate | 132.085M |
| Revenue actual | 135.063M |
| Revenue Surprise | 2.25% |
| Release date | May 02, 2025 |
| EPS estimate | $0.280 |
| EPS actual | $0.330 |
| EPS Surprise | 17.86% |
| Revenue estimate | 126.702M |
| Revenue actual | 126.205M |
| Revenue Surprise | -0.392% |
| Release date | Feb 07, 2025 |
| EPS estimate | $0.320 |
| EPS actual | $0.380 |
| EPS Surprise | 18.75% |
| Revenue estimate | 124.509M |
| Revenue actual | 121.75M |
| Revenue Surprise | -2.22% |
Last 4 Quarters for Proto Labs
Below you can see how PRLB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 07, 2025 |
| Price on release | $41.60 |
| EPS estimate | $0.320 |
| EPS actual | $0.380 |
| EPS surprise | 18.75% |
| Date | Price |
|---|---|
| Feb 03, 2025 | $41.64 |
| Feb 04, 2025 | $43.12 |
| Feb 05, 2025 | $44.25 |
| Feb 06, 2025 | $44.39 |
| Feb 07, 2025 | $41.60 |
| Feb 10, 2025 | $42.27 |
| Feb 11, 2025 | $43.26 |
| Feb 12, 2025 | $43.74 |
| Feb 13, 2025 | $45.03 |
| 4 days before | -0.0961% |
| 4 days after | 8.25% |
| On release day | 1.61% |
| Change in period | 8.14% |
| Release date | May 02, 2025 |
| Price on release | $38.35 |
| EPS estimate | $0.280 |
| EPS actual | $0.330 |
| EPS surprise | 17.86% |
| Date | Price |
|---|---|
| Apr 28, 2025 | $35.39 |
| Apr 29, 2025 | $35.41 |
| Apr 30, 2025 | $35.16 |
| May 01, 2025 | $35.80 |
| May 02, 2025 | $38.35 |
| May 05, 2025 | $39.04 |
| May 06, 2025 | $39.10 |
| May 07, 2025 | $38.67 |
| May 08, 2025 | $40.20 |
| 4 days before | 8.36% |
| 4 days after | 4.82% |
| On release day | 1.80% |
| Change in period | 13.59% |
| Release date | Jul 31, 2025 |
| Price on release | $43.12 |
| EPS estimate | $0.330 |
| EPS actual | $0.410 |
| EPS surprise | 24.24% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $39.11 |
| Jul 28, 2025 | $39.64 |
| Jul 29, 2025 | $40.02 |
| Jul 30, 2025 | $39.23 |
| Jul 31, 2025 | $43.12 |
| Aug 01, 2025 | $43.19 |
| Aug 04, 2025 | $43.35 |
| Aug 05, 2025 | $44.20 |
| Aug 06, 2025 | $44.96 |
| 4 days before | 10.25% |
| 4 days after | 4.27% |
| On release day | 0.162% |
| Change in period | 14.96% |
| Release date | Oct 31, 2025 |
| Price on release | $49.76 |
| EPS estimate | $0.390 |
| EPS actual | $0.470 |
| EPS surprise | 20.51% |
| Date | Price |
|---|---|
| Oct 27, 2025 | $54.35 |
| Oct 28, 2025 | $53.49 |
| Oct 29, 2025 | $52.67 |
| Oct 30, 2025 | $53.03 |
| Oct 31, 2025 | $49.76 |
| Nov 03, 2025 | $53.47 |
| Nov 04, 2025 | $48.28 |
| Nov 05, 2025 | $49.80 |
| Nov 06, 2025 | $48.64 |
| 4 days before | -8.45% |
| 4 days after | -2.25% |
| On release day | 7.46% |
| Change in period | -10.51% |
Proto Labs Earnings Call Transcript Summary of Q3 2025
Proto Labs reported record third-quarter 2025 results with revenue of $135.4 million, up 7.8% year-over-year (6.8% in constant currency). Key growth drivers were CNC machining (up 18.2% year-over-year; U.S. CNC +24%) and Proto Labs Network (network revenue $30.1 million, +16.2% in constant currency). Consolidated non-GAAP gross margin improved to 45.9% (up 110 bps sequentially); adjusted EBITDA was $21.1 million (15.6% of revenue) and non-GAAP EPS was $0.47. The company generated $29.1 million of operating cash flow in the quarter, returned $12.8 million via share repurchases, ended the quarter with $138.4 million of cash and investments and no debt. Management highlighted investments to expand factory CNC capacity, launch of advanced CNC capabilities and expanded e-commerce/digital ordering, and an ongoing strategic planning process with more detail expected in 2026. Cross-selling momentum: customers using both factory and network fulfillment in the trailing 12 months rose 35% quarter-over-quarter. Guidance for Q4 2025: revenue $125–$133 million (midpoint ≈ +6% y/y) and non-GAAP EPS $0.30–$0.38. Risks/areas to monitor: weaker European demand (Europe revenue down ~5% cc), 3D printing softness, injection molding near-flat (soft prototyping demand), and a decline in unique developers/customers despite higher revenue per customer. Overall, management is focused on "removing friction, expanding offerings and deepening customer relationships" to reaccelerate profitable growth.
